Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Matesanz
E Coll

Showing results (241-250 of 243) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 243 results.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 1, 2006
[Clinical research based nephrology (bases for the constitution of an Evidence Based Nephrology Group in the Spanish Society of Nephrology)]C Quereda, J Pascual, F García-López, et al.
Journal of Medicinal Chemistry|November 30, 2004
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channelMark T Bilodeau, Adrienne E Balitza, Timothy J Koester, et al.
Pageof 25

Showing results (241-250 of 243) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 243 results.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 1, 2006
[Clinical research based nephrology (bases for the constitution of an Evidence Based Nephrology Group in the Spanish Society of Nephrology)]C Quereda, J Pascual, F García-López, et al.
Journal of Medicinal Chemistry|November 30, 2004
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channelMark T Bilodeau, Adrienne E Balitza, Timothy J Koester, et al.
Pageof 25